Know Cancer

or
forgot password

Dysregulated Tyrosine Kinase Signaling in Leukemia


N/A
18 Years
N/A
Not Enrolling
Both
Leukemia

Thank you

Trial Information

Dysregulated Tyrosine Kinase Signaling in Leukemia


Purpose: to look at a number of proteins in the abnormal cells in the blood and/or bone
marrow. These proteins make a cell grow or prevent the cell from dying


Inclusion Criteria:



- Patients must have newly diagnosed or relapsed leukemia.

- Patients must sign an informed consent.

- Patients will not be excluded if they are receiving chemotherapy.

- Patients with CML, AML, ALL, T/NK leukemia, myelodysplasia, or myeloproliferative
disorders will be eligible.

- Patients must be => 18 years of age.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Principal Investigator

Ian Rabinowitz, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of New Mexico

Authority:

United States: Institutional Review Board

Study ID:

1602C

NCT ID:

NCT00277056

Start Date:

May 2002

Completion Date:

October 2005

Related Keywords:

  • Leukemia
  • leukemia
  • Leukemia

Name

Location

University of New MexicoAlbuquerque, New Mexico  87131